Cargando…
Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma
BACKGROUND: KIBRA has been suggested as a key regulator of the Hippo signaling pathway, regulating organ size, cell contact inhibition, tissue regeneration as well as tumorigenesis and cystogenesis. We recently reported that human KIBRA expression depends on a complex alternative CpG-rich promoter s...
Autores principales: | Schelleckes, Katrin, Schmitz, Boris, Ciarimboli, Giuliano, Lenders, Malte, Pavenstädt, Hermann J., Herrmann, Edwin, Brand, Stefan-Martin, Brand, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639574/ https://www.ncbi.nlm.nih.gov/pubmed/29046731 http://dx.doi.org/10.1186/s13148-017-0415-6 |
Ejemplares similares
-
ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRA
por: Schelleckes, Katrin, et al.
Publicado: (2018) -
Dose-Response of High-Intensity Training (HIT) on Atheroprotective miRNA-126 Levels
por: Schmitz, Boris, et al.
Publicado: (2017) -
Multifocal White Matter Lesions Associated with the D313Y Mutation of the α-Galactosidase A Gene
por: Lenders, Malte, et al.
Publicado: (2013) -
Cryptogenic stroke and small fiber neuropathy of unknown etiology in patients with alpha-galactosidase A -10T genotype
por: Schelleckes, Michael, et al.
Publicado: (2014) -
Neutralizing anti-drug antibodies in Fabry disease have no obvious clinical impact?
por: Lenders, Malte, et al.
Publicado: (2018)